White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment

Psychological Medicine

Volumn 43, Issue 11, 2013, Pages 2301-2309

  Wang, Q ^a   Cheung, C ^b   Deng, W ^a   Li, M ^a   Huang, C ^a   Ma, X ^a   Wang, Y ^a   Jiang, L ^a   Sham, P C ^b   Collier, D A ^c   Gong, Q ^d   Chua, S E ^b   McAlonan, G M ^e   Li, T ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d SICHUAN UNIVERSITY   (China)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

First episode; Longitudinal study; Microstructural deficits; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIPERAZINE DERIVATIVE; QUETIAPINE; QUINOLONE DERIVATIVE; RISPERIDONE; SULPIRIDE;

ADOLESCENT; ADULT; ANISOTROPY; ARTICLE; BRAIN; BRAIN MAPPING; CASE CONTROL STUDY; CINGULATE GYRUS; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL LOBE; HUMAN; IMAGE PROCESSING; MALE; MYELINATED NERVE; PATHOLOGY; PSYCHOLOGY; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANISOTROPY; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; DIBENZOTHIAZEPINES; DIFFUSION TENSOR IMAGING; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HALOPERIDOL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NERVE FIBERS, MYELINATED; PIPERAZINES; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892682644     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713000238     Document Type: Article

References (47)

1. Annett M (1970). A classification of hand preference by association analysis. British Journal of Psychology 61, 303-321.
2. Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO (2003). MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport 14, 2025-2029.
3. Bora E, Fornito A, Radua J, Walterfang M, Seal M, Wood SJ, Yucel M, Velakoulis D, Pantelis C (2011). Neuroanatomical abnormalities in schizophrenia:a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophrenia Research 127, 46-57.
4. Cahn W, Rais M, Stigter FP, van Haren NE, Caspers E, Hulshoff Pol HE, Xu Z, Schnack HG, Kahn RS (2009). Psychosis and brain volume changes during the first five years of schizophrenia. European Neuropsychopharmacology 19, 147-151.
5. Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR (2003). Complexity of prefrontal cortical dysfunction in schizophrenia:more than up or down. American Journal of Psychiatry 160, 2209-2215.
6. Carlsson A, Lindqvist M (1963). Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacologica et Toxicologica 20, 140-144.
7. Chan RC, Di X, McAlonan GM, Gong QY (2011). Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia:an activation likelihood estimation meta-analysis of illness progression. Schizophrenia Bulletin 37, 177-188.
8. Cheung V, Chiu CP, Law CW, Cheung C, Hui CL, Chan KK, Sham PC, Deng MY, Tai KS, Khong PL, McAlonan GM, Chua SE, Chen E (2011). Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychological Medicine 41, 1709-1719.
9. Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaemper N, Cheung V, Suckling J, McAlonan GM (2009). Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Psychological Medicine 39, 793-800.
10. Deng MY, McAlonan GM, Cheung C, Chiu CP, Law CW, Cheung V, Sham PC, Chen EY, Chua SE (2009). A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naive, newly diagnosed schizophrenia. Psychopharmacology 206, 437-446.
11. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA (2005). The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation:a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649-1661.
12. Federspiel A, Begre S, Kiefer C, Schroth G, Strik WK, Dierks T (2006). Alterations of white matter connectivity in first episode schizophrenia. Neurobiology of Disease 22, 702-709.
13. Goldman HH, Skodol AE, Lave TR (1992). Revising axis V for DSM-IV:a review of measures of social functioning. American Journal of Psychiatry 149, 1148-1156.
14. Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M (2003). Progressive structural brain abnormalities and their relationship to clinical outcome:a longitudinal magnetic resonance imaging study early in schizophrenia. Archives of General Psychiatry 60, 585-594.
15. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes:a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128-137.
16. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH (2006). Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 63, 731-740.
17. Hugenschmidt CE, Peiffer AM, Kraft RA, Casanova R, Deibler AR, Burdette JH, Maldjian JA, Laurienti PJ (2008). Relating imaging indices of white matter integrity and volume in healthy older adults. Cerebral Cortex 18, 433-442.
18. Hulshoff Pol HE, Kahn RS (2008). What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophrenia Bulletin 34, 354-366.
19. Kanaan R, Barker G, Brammer M, Giampietro V, Shergill S, Woolley J, Picchioni M, Toulopoulou T, McGuire P (2009a). White matter microstructure in schizophrenia:effects of disorder, duration and medication. British Journal of Psychiatry 194, 236-242.
20. Kanaan RA, Borgwardt S, McGuire PK, Craig MC, Murphy DG, Picchioni M, Shergill SS, Jones DK, Catani M (2009b). Microstructural organization of cerebellar tracts in schizophrenia. Biological Psychiatry 66, 1067-1069.
21. Kanaan RA, Shergill SS, Barker GJ, Catani M, Ng VW, Howard R, McGuire PK, Jones DK (2006). Tract-specific anisotropy measurements in diffusion tensor imaging. Psychiatry Research 146, 73-82.
22. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
23. Konopaske GT, Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA (2007). Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32, 1216-1223.
24. Konopaske GT, Dorph-Petersen KA, Sweet RA, Pierri JN, ZhangW, Sampson AR, Lewis DA (2008). Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biological Psychiatry 63, 759-765.
25. Koutsouleris N, Gaser C, Bottlender R, Davatzikos C, Decker P, Jager M, Schmitt G, Reiser M, Moller HJ, Meisenzahl EM (2010). Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis. Schizophrenia Research 123, 175-187.
26. Kubicki M, Westin CF, Nestor PG, Wible CG, Frumin M, Maier SE, Kikinis R, Jolesz FA, McCarley RW, Shenton ME (2003). Cingulate fasciculus integrity disruption in schizophrenia:a magnetic resonance diffusion tensor imaging study. Biological Psychiatry 54, 1171-1180.
27. Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, Chua S, McAlonan G (2011). Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophrenia Bulletin 37, 199-211.
28. Lewis DA (2011). Antipsychotic medications and brain volume:do we have cause for concern? Archives of General Psychiatry 68, 126-127.
29. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M (2005). Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry 62, 361-370.
30. Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H, Zhang T, Li X, Li D, Zou L, Tang H, Zhou XJ, Mechelli A, Collier DA, Sweeney JA, Li T, Gong Q (2009). Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia:an optimized voxel-based morphometry and resting state functional connectivity study. American Journal of Psychiatry 166, 196-205.
31. Lui S, Li T, Deng W, Jiang L, Wu Q, Tang H, Yue Q, Huang X, Chan RC, Collier DA, Meda SA, Pearlson G, Mechelli A, Sweeney JA, Gong Q (2010). Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by 'resting state' functional magnetic resonance imaging. Archives of General Psychiatry 67, 783-792.
32. McCormick L, Decker L, Nopoulos P, Ho BC, Andreasen N (2005). Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophrenia Research 80, 73-84.
33. Moncrieff J, Leo J (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine 40, 1409-1422.
34. Navari S, Dazzan P (2009). Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychological Medicine 39, 1763-1777.
35. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM (2011). Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biological Psychiatry 70, 88-96.
36. Peters BD, Blaas J, de Haan L (2010). Diffusion tensor imaging in the early phase of schizophrenia:what have we learned? Journal of Psychiatry Research 44, 993-1004.
37. Peters BD, de Haan L, Dekker N, Blaas J, Becker HE, Dingemans PM, Akkerman EM, Majoie CB, van Amelsvoort T, den Heeten GJ, Linszen DH (2008). White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology 58, 19-28.
38. Peters BD, Schmitz N, Dingemans PM, van Amelsvoort TA, Linszen DH, de Haan L, Majoie CB, den Heeten GJ (2009). Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis. Schizophrenia Research 111, 192-193.
39. Pressler M, Nopoulos P, Ho BC, Andreasen NC (2005). Insular cortex abnormalities in schizophrenia:relationship to symptoms and typical neuroleptic exposure. Biological Psychiatry 57, 394-398.
40. Rosenberger G, Kubicki M, Nestor PG, Connor E, Bushell GB, Markant D, Niznikiewicz M, Westin CF, Kikinis R, Saykin AJ, McCarley RW, Shenton ME (2008). Age-related deficits in fronto-temporal connections in schizophrenia:a diffusion tensor imaging study. Schizophrenia Research 102, 181-188.
41. Segal D, Koschnick JR, Slegers LH, Hof PR (2007). Oligodendrocyte pathophysiology:a new view of schizophrenia. International Journal of Neuropsychopharmacology 10, 503-511.
42. Stephan KE, Baldeweg T, Friston KJ (2006). Synaptic plasticity and dysconnection in schizophrenia. Biological Psychiatry 59, 929-939.
43. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Mandl RC, Collins DL, Evans AC, Kahn RS (2007). Focal gray matter changes in schizophrenia across the course of the illness:a 5-year follow-up study. Neuropsychopharmacology 32, 2057-2066.
44. Vernon AC, Natesan S, Modo M, Kapur S (2011). Effect of chronic antipsychotic treatment on brain structure:a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biological Psychiatry 69, 936-944.
45. Wang F, Sun Z, Cui L, Du X, Wang X, Zhang H, Cong Z, Hong N, Zhang D (2004). Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. American Journal of Psychiatry 161, 573-575.
46. Wang Q, Deng W, Huang C, Li M, Ma X, Wang Y, Jiang L, Lui S, Huang X, Chua SE, Cheung C, McAlonan GM, Sham PC, Murray RM, Collier DA, Gong Q, Li T (2011). Abnormalities in connectivity of white-matter tracts in patients with familial and non-familial schizophrenia. Psychological Medicine 41, 1691-1700.
47. White T, Magnotta VA, Bockholt HJ, Williams S, Wallace S, Ehrlich S, Mueller BA, Ho BC, Jung RE, Clark VP, Lauriello J, Bustillo JR, Schulz SC, Gollub RL, Andreasen NC, Calhoun VD, Lim KO (2011). Global white matter abnormalities in schizophrenia:a multisite diffusion tensor imaging study. Schizophrenia Bulletin 37, 222-232.